Cytopathology

News flow cytometer

Merck, a leading science and technology company, has now launched its new CellStream flow cytometry system.

April Journal-based learning

Each article’s contents should be read, researched and understood, and you should then come to a decision on each question. The pass mark is 17 out of 20 questions answered correctly. JBL exercises may be completed at any time until the published deadline date. Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

Primary HPV cervical screening

Following meetings with the British Association for Cytopathology (BAC), Public Health England (PHE) and the IBMS, the following has been agreed.

British Journal of Biomedical Science Issue 2 2018: a synopsis

Issue 2 of our journal is now completed. By the time you read this, the hardcopy may already have landed on your doormats, and those of you who have been to the website will already have accessed and read some of the papers. Editor Andrew Blann outlines the content in the latest issue.

Managing uncertainty in andrology

With andrology gaining more prominence as a discipline, David Sanders talks through the pre-examination process.

Congress update: real science, relevance

Sarah May, Deputy Chief Executive at the IBMS, explains the approach behind this year’s Congress.

How to…monitor a clinical service using audit

Following the completion of a high-quality audit, the team at Manchester Royal Infirmary’s cytology department offer guidance on monitoring a clinical service.

A desperate need for good leaders

Shahid Nazir Muhammad, a Specialist Biomedical Scientist, looks at chronic kidney disease and the need for compassionate, nurturing leaders in the field.

Life in a bubble

Biomedical engineers may have found a way of combating one of the deadliest forms of cancer, pancreatic cancer, with a diagnostic method that can catch it, even at its early stages.

Breast Cancer: Map holds hope for future

Scientists have created a “map” linking the shape of breast cancer cells to genes turned on and off, and matched it to real disease outcomes.

Top